Antitrust Case Filings
To filter the list of cases, select desired options from the left navigation pane.
View the list of NAICS and SIC industry codes used by the Division. To view all industry codes, visit Census.gov.
U.S. v. William N. Harwin
Dr. William Harwin was charged with participating in a conspiracy to suppress and eliminate competition by agreeing to allocate the provision of medical and radiation oncology services. While he was President and Managing Physician Partner of Florida Cancer Specialists (FCS), Harwin and his co-conspirators agreed not to compete to provide chemotherapy and radiation treatments to cancer patients in Southwest Florida. Beginning as early as 1999 and continuing until at least 2016, Harwin entered into an illegal agreement that allocated chemotherapy treatments to FCS and radiation treatments to a competing oncology group.
Jeffrey Sulitzer, et al. v. Joseph Tippins, et al.
U.S. v. Anheuser-Busch InBev SA/NV, et al.
U.S. v. Evans Concrete, LLC, et al.
One company and four individuals, Evans Concrete LLC, James Clayton Pedrick, Gregory Hall Melton, John “David” Melton, and Timothy “Bo” Strickland, were charged with participating in a conspiracy to fix prices, rig bids, and allocate markets. The conduct applied to the sale of ready-mix concrete used in residential, commercial and public projects in the greater Savannah, Georgia area. The conduct began at least as early as 2010 and continued until in or about July 2016. James Clayton Pedrick is also charged with making false statements and Timothy “Bo” Strickland is charged with making false statements and perjury.
U.S. v. Teva Pharmaceuticals USA Inc. and Glenmark Pharmaceuticals Inc., USA
Teva Pharmaceuticals USA Inc. was charged with participating in three conspiracies to suppress and eliminate competition by agreeing to fix prices, allocate customers, and rig bids for generic drugs. In the first count, Glenmark was charged along with Teva with knowingly entering into and engaging in a conspiracy to suppress and eliminate competition by agreeing to increase and maintain prices of pravastatin and other generic drugs sold in the United States. The charged conspiracies took place between 2013 and 2015.
U.S. v. Geisinger Health and Evangelical Community Hospital
Garret Sitts, et al., v. Dairy Farmers of America, Inc. and Dairy Marketing Services, LLC
U.S. v. Taro Pharmaceuticals U.S.A., Inc.
Taro Pharmaceuticals U.S.A., Inc. was charged with participating in two conspiracies to suppress and eliminate competition by agreeing to fix prices, allocate customers, and rig bids for generic drugs. The charged conspiracies took place between 2013 and 2015.
Oxbow Carbon & Minerals LLC, et al. v. Union Pacific Railroad Co., et al.
Indirect Purchaser Plaintiffs, et al. v. Irico Group Corp., et al.
U.S. v. Cajan Welding & Rentals, Ltd.
U.S. v. Glenmark Pharmaceuticals Inc., USA
Glenmark Pharmaceuticals Inc., USA is charged with knowingly entering into and engaging in a conspiracy to suppress and eliminate competition by agreeing to increase and maintain prices of pravastatin and other generic drugs sold in the United States. The charged conspiracy began at least as early as May 2013 and continued at least until December 2015.